Janice F. Eakle

Enzalutamide for the Treatment of Androgen Receptor–Expressing Triple-Negative Breast Cancer

Tiffany A. Traina, Kathy D. Miller, Denise A. Yardley et al. · Journal of Clinical Oncology · 2018 · 519 citations · Full text

Medicine, Oncology, Pharmacology +17

Capecitabine and Oxaliplatin in the Preoperative Multimodality Treatment of Rectal Cancer: Surgical End Points From National Surgical Adjuvant Breast and Bowel Project Trial R-04

Michael J. O’Connell, Linda H. Colangelo, Robert W. Beart et al. · Journal of Clinical Oncology · 2014 · 441 citations · Full text

Medicine, Oncology, Surgery +16

Neoadjuvant 5-FU or Capecitabine Plus Radiation With or Without Oxaliplatin in Rectal Cancer Patients: A Phase III Randomized Clinical Trial

Carmen J. Allegra, Greg Yothers, Michael J. O’Connell et al. · JNCI Journal of the National Cancer Institute · 2015 · 328 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Incidence and time course of everolimus-related adverse events in postmenopausal women with hormone receptor-positive advanced breast cancer: insights from BOLERO-2

Hope S. Rugo, Kathleen I. Pritchard, Michael Gnant et al. · Annals of Oncology · 2014 · 127 citations · Full text

Medicine, Oncology, Pharmacology +17

Effect of Everolimus on Bone Marker Levels and Progressive Disease in Bone in BOLERO-2

Michael Gnant, José Baselga, Hope S. Rugo et al. · JNCI Journal of the National Cancer Institute · 2013 · 98 citations · Full text

Medicine, Oncology, Pharmacology +17